Russo Rene Insider Profile
11 Followers
Russo Rene, President & CEO, Director at Xilio Therapeutics, holds 325.42K shares in Xilio Therapeutics (Ticker: XLO), holds ― shares in X4 Pharmaceuticals (Ticker: XFOR), holds ― shares in Invivyd (Ticker: IVVD).
Russo Rene has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Russo Rene holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Russo Rene
Russo Rene's Trading History
Xilio Therapeutics
Jan 05, 2026
President & CEO, Director
Uninformative Buy
28.32K
$2.91M
X4 Pharmaceuticals
―
Director
―
―
Invivyd
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Russo Rene's performance on stock
You May Also Like
Russo Rene insider profile FAQ
What is the percentage of profitable transactions made by Russo Rene?
The percentage of profitable transactions made by Russo Rene is ―.
What is the average return per transaction made by Russo Rene?
The average return per transaction made by Russo Rene is ―.
What stocks does Russo Rene hold?
Russo Rene holds: XLO, XFOR, IVVD stocks.
What was Russo Rene’s latest transaction?
Russo Rene latest transaction was an Uninformative Buy of $28.32K.
What was Russo Rene's most profitable transaction?
Russo Rene’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Russo Rene's role in Xilio Therapeutics?
Russo Rene's role in Xilio Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.